Pirfenidone: View Uses, Side Effects and Medicines
PIRFENOID 200 is a widely prescribed medication used primarily for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and debilitating lung disease that leads to scarring of lung tissue. The active ingredient in PIRFENOID 200 is Pirfenidone, which plays a crucial role in slowing the progression of lung fibrosis by reducing inflammation and fibrosis in the lungs. Available in a 200 mg dose, this formulation is highly effective in managing the symptoms of IPF and improving the quality of life for affected individuals.
This article will provide an in-depth look at the composition, key features, usage, and benefits of PIRFENOID 200.
Composition of PIRFENOID 200
The active ingredient in PIRFENOID 200 is Pirfenidone (200 mg), a potent antifibrotic and anti-inflammatory drug. Pirfenidone works by inhibiting the growth of fibrous tissue in the lungs, which helps in reducing the fibrosis or scarring process associated with conditions like idiopathic pulmonary fibrosis (IPF).
Pirfenidone (200 mg): Pirfenidone is a multitargeted agent that exerts several effects, including anti-inflammatory, antifibrotic, and antioxidant properties. It helps by blocking key molecular pathways involved in the fibrosis process, thus slowing down the deterioration of lung function in patients with IPF.
Other excipients: The formulation contains excipients that assist in the stability, absorption, and effectiveness of the active ingredient. These help in the proper release and absorption of Pirfenidone.
Key Features and Ingredients
Pirfenidone (200 mg): The active ingredient that effectively treats idiopathic pulmonary fibrosis (IPF) by targeting the fibrotic processes in the lungs. Pirfenidone helps to reduce the rate of lung function decline, improve exercise tolerance, and provide symptomatic relief.
Anti-inflammatory Action: Pirfenidone has significant anti-inflammatory properties, which help to reduce the chronic inflammation that contributes to the progression of IPF. By inhibiting the release of pro-inflammatory cytokines, it helps in controlling the inflammatory response that leads to lung damage.
Antifibrotic Properties: Pirfenidone prevents the overproduction of collagen, which is responsible for the fibrosis (scarring) of lung tissue. This action is vital in slowing the progression of IPF and maintaining lung function for a longer period.
Oral Administration: PIRFENOID 200 is taken orally, providing a convenient and straightforward method of administering the medication to patients.
Usage and Administration
PIRFENOID 200 is usually prescribed by a healthcare provider and should be taken according to their instructions. It is typically available in the form of tablets, which should be swallowed whole with water. The dosage and frequency of administration depend on the severity of the condition and the doctor’s recommendations.
Standard Dosage: The typical starting dosage is 200 mg taken three times a day with food. Depending on the patient’s response and tolerance, the dosage may be adjusted by the healthcare provider.
For Idiopathic Pulmonary Fibrosis (IPF): PIRFENOID 200 is primarily used to slow the progression of IPF, improve lung function, and enhance the patient\'s overall quality of life. It is not a cure for IPF but can help to manage the disease effectively.
Precautions: Patients should follow the prescribed dosage and avoid exceeding the recommended amount. Regular follow-up visits with the healthcare provider are essential to monitor progress and adjust the treatment as necessary.
Benefits of PIRFENOID 200
Slows Disease Progression in IPF: The primary benefit of PIRFENOID 200 is its ability to slow the progression of idiopathic pulmonary fibrosis (IPF). By targeting the fibrotic process, Pirfenidone reduces the accumulation of scar tissue in the lungs, helping to preserve lung function over time.
Reduces Inflammation: Pirfenidone exerts significant anti-inflammatory effects, helping to control the chronic inflammation that is a hallmark of IPF. This helps to reduce the damage caused by excessive inflammation in the lungs.
Improves Lung Function: Regular use of PIRFENOID 200 has been shown to improve lung function and exercise tolerance in individuals with IPF. By preventing the decline of lung capacity, the medication helps patients breathe more easily and engage in physical activities with less difficulty.
Improves Quality of Life: PIRFENOID 200 can improve the overall quality of life for people suffering from IPF. By reducing symptoms such as shortness of breath, fatigue, and coughing, it allows patients to better manage daily tasks and maintain a more active lifestyle.
Well-Tolerated with Fewer Side Effects: Pirfenidone is generally well-tolerated by most patients, with fewer and less severe side effects compared to other medications used to treat IPF. While some mild side effects like nausea and fatigue may occur, they are typically manageable and diminish with continued use.
Non-Chemotherapy Option: Unlike traditional cancer treatments or other aggressive therapies, PIRFENOID 200 provides a non-invasive, oral treatment option for managing IPF, which is often preferred by patients due to its convenience.
Helps in Long-Term Disease Management: PIRFENOID 200 is effective for long-term management of IPF, offering continuous disease control and symptom relief, which can delay the need for more invasive treatments or lung transplants.
Conclusion
PIRFENOID 200, containing Pirfenidone (200 mg), is an effective and well-tolerated medication for managing idiopathic pulmonary fibrosis (IPF). It works by targeting the fibrosis and inflammation in the lungs, helping to slow disease progression, improve lung function, and enhance quality of life for patients. While it is not a cure for IPF, PIRFENOID 200 is an essential part of long-term management for those living with this chronic and progressive condition. Always consult with a healthcare professional before starting any new treatment to ensure it is the right choice for your specific condition and needs.Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma\'s product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
